Noelle Frey, MD, MSCE
Noelle Frey, MD, MSCE
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
2 West Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-662-6901
Email:
noelle.frey@uphs.upenn.edu
noelle.frey@uphs.upenn.edu
Education:
B.S. (Molecular Biophysics and Biochemistry)
Yale University, 1996.
M.D. (Medicine)
Columbia University, 2001.
M.S. (Clinical Epidemiology & Biostatistics)
University of Pennsylvania, 2012.
Permanent linkB.S. (Molecular Biophysics and Biochemistry)
Yale University, 1996.
M.D. (Medicine)
Columbia University, 2001.
M.S. (Clinical Epidemiology & Biostatistics)
University of Pennsylvania, 2012.
Description of Research Expertise
Researh Interests: Early phase clinical trial design and translational research for subjects with hematologic malignancies and subjects undergoing allogeneic stem cell transplantation.Active Research Projects:
The establishment of a peripheral blood tissue bank and clinical database for subjects undergoing allogeneic stem cell transplantation. Several active projects assessing T cell function as it relates to disease relapse and GVHD are ongoing.
A Phase I/II clinical trial using single agent eltrombopag for patients with acute myelogenous leukemia.
A Phase I/II clinical trial using single agent TL32711 (a smac mimetic) for patients with acute myelogenous leukemia.
A retrospective multicenter descriptional study sponsored by the International Bone Marrow Transplant Registry and National Marrow Donor Program to evaluate donor derived malignancies after stem cell transplantation.
A retrospective multicenter cohort study sponsored by the International Bone Marrow Transplant Registry to evaluate outcomes of recipients of a fresh versus a frozen allograft.
A retrospective multicenter study sponsored by the International Bone Marrow Transplant Registry to evaluate outcomes for patients who relapse after allogeneic stem cell transplantation who receive either DLI or second SCT